ciprofloxacin has been researched along with Leishmaniasis, Visceral in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bharate, SB | 1 |
Bharate, JB | 1 |
Khan, SI | 1 |
Tekwani, BL | 1 |
Jacob, MR | 1 |
Mudududdla, R | 1 |
Yadav, RR | 1 |
Singh, B | 2 |
Sharma, PR | 1 |
Maity, S | 1 |
Khan, IA | 1 |
Vishwakarma, RA | 1 |
Sanal, O | 1 |
Turkkani, G | 1 |
Gumruk, F | 1 |
Yel, L | 1 |
Secmeer, G | 1 |
Tezcan, I | 1 |
Kara, A | 1 |
Ersoy, F | 1 |
Muñoz Sanz, A | 1 |
3 other studies available for ciprofloxacin and Leishmaniasis, Visceral
Article | Year |
---|---|
Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
Topics: Antiprotozoal Agents; Drug Discovery; Humans; Indoles; Inhibitory Concentration 50; Leishmania donov | 2013 |
A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis.
Topics: Amphotericin B; Anti-Infective Agents; Antiprotozoal Agents; Child, Preschool; Ciprofloxacin; Geneti | 2007 |
[Visceral leishmaniasis and ciprofloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Leishmaniasis, Visceral | 1996 |